A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1016/j.heliyon.2023.e21001
dc.identifier.other
WOS:001107794400001
dc.description.volume
dc.description.issue
Publisher
CELL PRESS
DOI
10.1016/j.heliyon.2023.e21001